2 studies found for:    21633166 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Suspended Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer;   HER2-negative Breast Cancer;   Progesterone Receptor-negative Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Triple-negative Breast Cancer
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Doxorubicin;   Drug: Cyclophosphamide;   Drug: Veliparib
2 Not yet recruiting AR-inhibitor Bicalutamide in Treating Patients With TNBC
Condition: Breast Neoplasms
Interventions: Drug: Bicalutamide;   Other: Physician's Choice

Indicates status has not been verified in more than two years